Recall Register

Drug recall: Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by…

Class II FDA enforcement event 94519. Recall start date: . Status in the FDA record: Completed.

Reason for recall, in the words of FDA

Failed Impurities/Degradation Specifications

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Viatris Inc started this drug recall on 30 Apr 2024. The firm address in the FDA record is in Canonsburg, PA. FDA put the recall in Class II. FDA event 94519 has 2 product records. The first FDA enforcement report date is 24 Jul 2024. The record gives the status Completed.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

U.S. Nationwide

Recalling firm

Viatris Inc, Canonsburg, PA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 94519: product records
Recall numberProductQuantityClassStatusReport date
D-0602-2024Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-1012,691 bottlesClass IICompleted24 Jul 2024
D-0603-2024Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-103,694 bottlesClass IICompleted24 Jul 2024

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2024
319
Share of these events in Class II
71%
Product records in this event
2Median of the firm: 1
Events of the firm on the register
11

Other events of the firm

Other FDA enforcement events of Viatris Inc
InitiatedProduct (first record)TypeClassRecords
17 Mar 2026Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLCDrugClass II1
23 Dec 2024Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, MoDrugClass II2
18 Nov 2024Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles DrugClass II11
25 Apr 2024Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WVDrugClass III1
25 May 2023Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampulDrugClass II1
21 Oct 2022Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made iDrugClass II1
7 Oct 2022Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous UseDrugClass I1
21 Sep 2022Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, RxDrugClass II1
28 Apr 2022Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, DiDrugClass II1
28 Apr 2022alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 0797DrugClass II1

Viatris Inc: all 11 events

Official channels

Cite this page

Recall Register. FDA enforcement event 94519. https://recallregister.com/fda/ii/94519/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: U.S. Nationwide
What quantity of product is in FDA event 94519?
The event has 2 product records. The first record gives this quantity: 12,691 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2024 have the same class?
71% of the 319 drug events that started in 2024 are in Class II.